Appointments

K2 Therapeutics Appoints Dr. Ying Huang as Chief Executive Officer

City Therapeutics Appoints Mary Beth DeLena, J.D., as Chief Legal Officer

City Therapeutics Appoints Keith Regnante, MBA, as Chief Financial Officer

Pace® Appoints Andy Fenny as President of Pace® Life Sciences

Erasca Appoints Charles S. Fuchs, M.D., M.P.H., as President of Research and Development

Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer

Danaher Appoints Julie Sawyer Montgomery as President and Chief Executive Officer

Codexis Appoints David Butler, Ph.D., to Strategic Advisory Board

Terremoto Biosciences Appoints James Christensen, Ph.D., as Chief Executive Officer and President